Clinical Trials Browser

Phase 2 × Stomach Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00032123 2013-06-24

Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Phase 2 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms